TARGETED THERAPY ADAPTED TO TUMOR BIOLOGY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA OR HEPATOCHOLANGIOCARCINOMA REFRACTORY TO ATEZOLIZUMAB/BEVACIZUMAB

被引：0
|
作者：
Limousin, Wendy [1 ]
Laurent-Puig, Pierre [2 ,3 ,4 ]
Ziol, Marianne [1 ,5 ,6 ]
Ganne-Carrie, Nathalie [1 ,7 ]
Nahon, Pierre [1 ,7 ]
Ait-Omar, Amal [8 ]
Seror, Olivier [1 ,9 ]
Sidali, Sabrina [10 ]
Campani, Claudia [1 ,11 ]
Blanc, Pierre [3 ]
Lermine, Alban [3 ]
Marisa, Laetitia [3 ]
Zucman-Rossi, Jessica [1 ]
Nault, Jean-Charles [1 ,7 ]
机构：
[1] Cordeliers Res Ctr, Funct Genom Solid Tumors Team, Paris, France
[2] Cordeliers Res Ctr, INSERM, CNRS, Snc 5096, Paris, France
[3] Med Biol Lab Seqoia, Redwood City, CA USA
[4] European Hosp George Pompidou, Dept Genom Med Tumours & Canc, Paris, France
[5] Avicenne Hosp, Pathol, Bobigny, France
[6] Avicenne Hosp, Ctr Ressources Biol, Bobigny, France
[7] Avicenne Hosp, Hepatol, Bobigny, France
[8] Avicenne Hosp, Gastroenterol, Bobigny, France
[9] Avicenne Hosp, Intervent Radiol, Bobigny, France
[10] Beaujon Hosp, Hepatol, Clichy, France
[11] Univ Florence, Florence, Italy
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
194
引用
收藏
页码：S203 / S204
页数：2
相关论文
共 50 条
  • [1] Analysis of the tumor microenvironment in ineffective patients of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
    Kobayashi, Kazufumi
    Ogasawara, Sadahisa
    Ishino, Takamasa
    Unozawa, Hidemi
    Nakagawa, Miyuki
    Fujiwara, Kisako
    Sakuma, Takafumi
    Fujita, Naoto
    Kanzaki, Hiroaki
    Koroki, Keisuke
    Nakamura, Masato
    Kiyono, Soichiro
    Kanogawa, Naoya
    Kondo, Takayuki
    Saito, Tomoko
    Nakagawa, Ryo
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Chiba, Tetsuhiro
    Kato, Naoya
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [2] Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy
    Kurebayashi, Yutaka
    Tsujikawa, Hanako
    Sugimoto, Katsutoshi
    Yunaiyama, Daisuke
    Araki, Yoichi
    Saito, Kazuhiro
    Takahashi, Hiroshi
    Kakegawa, Tatsuya
    Wada, Takuya
    Tomita, Yusuke
    Abe, Masakazu
    Yoshimasu, Yu
    Takeuchi, Hirohito
    Hirata, Taiki
    Sakamaki, Kentaro
    Kakimi, Kazuhiro
    Nagao, Toshitaka
    Itoi, Takao
    Sakamoto, Michiie
    HEPATOLOGY RESEARCH, 2023, 53 (10) : 1008 - 1020
  • [3] Therapy with Atezolizumab and Bevacizumab prolongs Life of Patients with hepatocellular Carcinoma
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (09):
  • [4] Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab
    Limousin, Wendy
    Laurent-Puig, Pierre
    Ziol, Marianne
    Ganne-Carrie, Nathalie
    Nahon, Pierre
    Ait-Omar, Amal
    Seror, Olivier
    Sidali, Sabrina
    Campani, Claudia
    Blanc, Pierre
    Lermine, Alban
    Marisa, Laetitia
    Zucman-Rossi, Jessica
    Nault, Jean-Charles
    JOURNAL OF HEPATOLOGY, 2023, 79 (06) : 1450 - 1458
  • [5] Atezolizumab and Bevacizumab Targeted-Therapy in Advanced Hepatocellular Carcinoma: A Systematic Review of Cost-effectiveness Analyses
    Mohammadnezhad, Ghader
    Esmaily, Hadi
    Talebi, Maryam
    Jafari, Matin
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (02) : 625 - 637
  • [6] Atezolizumab plus bevacizumab for advanced, unresectable hepatocellular carcinoma
    Tsilimigras, Diamantis I.
    Moris, Dimitrios
    JOURNAL OF BUON, 2021, 26 (02): : 637 - 638
  • [7] First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Mahipal, Amit
    Jin, Zhaohui
    BIOMEDICINES, 2022, 10 (06)
  • [8] Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma
    Hwang, Sang Youn
    Woo, Hyun Young
    Heo, Jeong
    Kim, Hyung Jun
    Park, Young Joo
    Yi, Ki Youn
    Lee, Yu Rim
    Park, Soo Young
    Chung, Woo Jin
    Jang, Byoung Kuk
    Tak, Won Young
    CANCERS, 2024, 16 (04)
  • [9] Association between tumor morphology and efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
    Ishihara, Nobuaki
    Komatsu, Shohei
    Sofue, Keitaro
    Ueshima, Eisuke
    Yano, Yoshihiko
    Fujishima, Yoshimi
    Ishida, Jun
    Kido, Masahiro
    Gon, Hidetoshi
    Fukushima, Kenji
    Urade, Takeshi
    Yanagimoto, Hiroaki
    Toyama, Hirochika
    Ueda, Yoshihide
    Kodama, Yuzo
    Murakami, Takamichi
    Fukumoto, Takumi
    HEPATOLOGY RESEARCH, 2024, 54 (08) : 773 - 780
  • [10] Result of atezolizumab plus bevacizumab for advanced or metastatic hepatocellular carcinoma in Vietnamese patients
    Hoang, H. T.
    ANNALS OF ONCOLOGY, 2024, 35 : S88 - S88
12345